Article

Jenner, Matthew W, Pawlyn, Charlotte, Davies, Faith E, Menzies, Tom, Hockaday, Anna, Olivier, Catherine, Jones, John R, Karunanithi, Kamaraj, Lindsay, Jindriska, Kishore, Bhuvan, Cook, Gorden, Drayson, Mark T, Kaiser, Martin F, Owen, Roger G, Gregory, Walter, Cairns, David A, Morgan, Gareth and Jackson, Graham H (2022) The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages: results from ‘Myeloma XI’, a multicentre, open-label, randomised, phase III trial. British Journal of Haematology. pp. 1-13. ISSN 0007-1048

Saleem, Kainat, Franz, Joseph, Klem, Mary Lou, Yabes, Jonathan G, Boyiadzis, Michael, Jones, John R, Shaikh, Nader and Lontos, Konstantinos (2022) Second primary malignancies in patients with haematological cancers treated with lenalidomide: a systematic review and meta-analysis. Lancet Haematol. ISSN 2352-3026

Coulson, Amy Beth, Royle, Kara-Louise, Pawlyn, Charlotte, Cairns, David A, Hockaday, Anna, Bird, Jennifer, Bowcock, Stella, Kaiser, Martin, de Tute, Ruth, Rabin, Neil, Boyd, Kevin, Jones, John, Parrish, Christopher, Gardner, Hayley, Meads, David, Dawkins, Bryony, Olivier, Catherine, Henderson, Rowena, Best, Phillip, Owen, Roger, Jenner, Matthew, Kishore, Bhuvan, Drayson, Mark, Jackson, Graham and Cook, Gordon (2022) Frailty-adjusted therapy in Transplant Non-Eligible patients with newly diagnosed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trial. BMJ Open, 12. e056147. ISSN 2044-6055

Nandra, Taran K, Devi, Amarpreet and Jones, John R (2022) Multiple myeloma: what a non-haematologist should know. Clinical Medicine, 22. pp. 230-233. ISSN 1470-2118

de Tute, Ruth M, Pawlyn, Charlotte, Cairns, David A, Davies, Faith E, Menzies, Tom, Rawstron, Andy, Jones, John R, Hockaday, Anna, Henderson, Rowena, Cook, Gordon, Drayson, Mark T, Jenner, Matthew W, Kaiser, Martin F, Gregory, Walter M, Morgan, Gareth J, Jackson, Graham H and Owen, Roger G (2022) Minimal residual disease after autologous stem-cell transplant for patients with myeloma: prognostic significance and the impact of lenalidomide maintenance and molecular risk. Journal of Clinical Oncology. pp. 1-12. ISSN 0732-183X

Botham, Jed, Shilling, Valerie and Jones, John (2021) Patient and public understanding of the concept of ‘personalised medicine’ in relation to cancer treatment: a systematic review. Future Healthcare Journal, 8 (3). e703-e708. ISSN 2514-6645

Jones, J R, Barber, A, Le Bihan, Y V, Weinhold, N, Ashby, C, Walker, B A, Wardell, C P, Wang, H, Kaiser, M F, Jackson, G H, Davies, F E, Chopra, R, Morgan, G J and Pawlyn, C (2021) Mutations in CRBN and other cereblon pathway genes are infrequently associated with acquired resistance to immunomodulatory drugs. Leukemia, 35. pp. 3017-3020. ISSN 0887-6924

Jones, John, Jackson, Graham and Pawlyn, Jones (2021) Safety of lenalidomide for maintenance treatment of patients with multiple myeloma following autologous stem cell transplantation. Expert Opinion on Drug Safety. ISSN 1474-0338